Using Real World Data to Guide Precision Oncology Drug Development
Precision medicine is the commitment to deliver the right therapy to the right patient at the right time. This is a challenging goal, especially in oncology, given the wide diversity of diseases and patients. To address the challenges, drug developers are increasingly analyzing real world data (RWD) to generate real-world evidence (RWE) to complement what can be learned from traditional randomized, controlled clinical trials (RCTs).
View
Nov 25, 2024
